ArticleScientific reports2025
An attention enhanced dilated bottleneck network for kidney disease classification.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Explainable AI in kidney stone detection and segmentation: a mini review.Frontiers in digital health · 2026Review
- Advanced transformer with attention-based neural network framework for precise renal cell carcinoma detection using histological kidney images.Scientific reports · 2025Article
- KidneyNeXt: A Lightweight Convolutional Neural Network for Multi-Class Renal Tumor Classification in Computed Tomography Imaging.Journal of clinical medicine · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Computer-Aided Design (CAD) techniques have been developed to assist nephrologists by optimising clinical workflows, ensuring accurate results and effectively handling extensive datasets. The proposed work introduces a Dilated Bottleneck Attention-based Renal Network (DBAR-Net) to automate the diagnosis and classification of kidney diseases like cysts, stones, and tumour. To overcome the challenges caused by complex and overlapping features, the DBAR_Net model implements a multi-feature fusion technique. Two fold convolved layer normalization blocks [Formula: see text]& [Formula: see text] capture fine-grained detail and abstract patterns to achieve faster convergence and improved robustness. Spatially focused features and channel-wise refined features are generated through dual bottleneck attention modules [Formula: see text] to improve the representation of convolved features by highlighting channel and spatial regions resulting enhanced interpretability and feature generalisation. Additionally, adaptive contextual features are obtained from a dilated convolved layer normalisation block [Formula: see text], which effectively captures contextual insights from semantic feature interpretation. The resulting features are fused additively and processed through a linear layer with global average pooling and layer normalization. This combination effectively reduces spatial dimensions, internal covariate shifts and improved generalization along with essential features. The proposed approach was evaluated using the CT KIDNEY DATASET that includes 8750 CT images classified into four categories: Normal, Cyst, Tumour, and Stone. Experimental results showed that [Formula: see text] improved feature detection ability enhanced the performance of DBAR_Net model attaining a F1 score as 0.98 with minimal computational complexity and optimum classification accuracy of 98.86%. The integration of these blocks resulted in precise multi-class kidney disease detection, thereby leading to the superior performance of DBAR_Net compared to other transfer learning models like VGG16, VGG19, ResNet50, EfficientNetB0, Inception V3, MobileNetV2, and Xception.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.